Literature DB >> 3709616

The effects of domperidone on the absorption of levodopa in normal subjects.

I D Bradbrook, H C Gillies, P J Morrison, H J Rogers.   

Abstract

The effect of simultaneous oral administration of 20, 40, or 80 mg domperidone on the pharmacokinetics of an oral 500 mg dose of levodopa was studied in eight normal women. No significant differences in maximum plasma levodopa concentration, the time of its attainment, or the area under the plasma levodopa concentration versus time profile occurred. Domperidone significantly reduced the incidence of adverse gastrointestinal effects due to levodopa administration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709616     DOI: 10.1007/bf00615966

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Metoclopramide in Parkinson's disease.

Authors:  D N Bateman; C Kahn; N J Legg; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

2.  Variability of L-dopa absorption in man.

Authors:  D N Wade; P T Mearrick; D J Birkett; J Morris
Journal:  Aust N Z J Med       Date:  1974-04

3.  Metoclopramide, gastric emptying and L-dopa absorption.

Authors:  P T Mearrick; D N Wade; D J Birkett; J Morris
Journal:  Aust N Z J Med       Date:  1974-04

4.  L-dopa treatment failure: explanation and correction.

Authors:  L Rivera-Calimlim; C A Dujovne; J P Morgan; L Lasagna; J R Bianchine
Journal:  Br Med J       Date:  1970-10-10

5.  Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.

Authors:  J D Parkes; A G Debono; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

6.  Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection.

Authors:  C R Freed; P A Asmus
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

7.  Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidone.

Authors:  J M Van Nueten; C Ennis; L Helsen; P M Laduron; P A Janssen
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

8.  Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.

Authors:  Y Agid; P Pollak; A M Bonnet; J L Signoret; F Lhermitte
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

9.  Domperidone and levodopa in Parkinson's disease.

Authors:  J S Shindler; G T Finnerty; K Towlson; A L Dolan; C L Davies; J D Parkes
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

10.  Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient.

Authors:  M A Evans; G A Broe; E J Triggs; M Cheung; H Creasey; P D Paull
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

View more
  3 in total

1.  The effect of dopamine on conditioned placebo analgesia in healthy individuals: a double-blind randomized trial.

Authors:  Matthias Zunhammer; Magnus Gerardi; Ulrike Bingel
Journal:  Psychopharmacology (Berl)       Date:  2018-06-25       Impact factor: 4.530

Review 2.  Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.

Authors:  J M Greiff; D Rowbotham
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 3.  Antiparkinsonian agents. Drug interactions of clinical significance.

Authors:  R F Pfeiffer
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.